HORMONE-TREATMENT FOR THE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS

被引：0
|
作者：
MOLINIE, P
CHAUMERLIAC, P
GUILHAUME, B
LUTON, JP
机构：
来源：
SEMAINE DES HOPITAUX | 1989年 / 65卷 / 34期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2124 / 2133
页数：10
相关论文
共 50 条
  • [21] Prevention and early treatment of postmenopausal osteoporosis
    Ringe, JD
    GYNAKOLOGE, 1998, 31 (10): : 870 - 876
  • [22] Tibolone for prevention and treatment of postmenopausal osteoporosis
    Ettinger, Bruce
    MATURITAS, 2007, 57 (01) : 35 - 38
  • [23] POSTMENOPAUSAL OSTEOPOROSIS - CAUSE, PREVENTION AND TREATMENT
    GORDAN, GS
    CLINICS IN OBSTETRICS AND GYNAECOLOGY, 1977, 4 (01): : 169 - 179
  • [24] POSTMENOPAUSAL OSTEOPOROSIS - PREVENTION AND TREATMENT WITH CALCITONIN
    PRELEVIC, GM
    ADASHI, EY
    GYNECOLOGICAL ENDOCRINOLOGY, 1992, 6 (02) : 141 - 147
  • [25] Role of menopausal hormone therapy in the prevention of postmenopausal osteoporosis
    Na, Zhao
    Wei, Wei
    Xu, Yingfang
    Li, Dong
    Yin, Beili
    Gu, Weiqun
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [26] HORMONE REPLACEMENT FOR EARLY AND LATE PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS
    RIBOT, C
    TREMOLLIERES, F
    POUILLES, JM
    PRESSE MEDICALE, 1995, 24 (21): : 999 - 1002
  • [27] Raloxifene hydrochloride - Treatment of osteoporosis prevention of osteoporosis treatment of postmenopausal syndrome
    不详
    DRUGS OF THE FUTURE, 2001, 26 (07) : 713 - 714
  • [28] SERMs in the prevention and treatment of postmenopausal osteoporosis: an update
    Kulak Junior, Jaime
    Moreira Kulak, Carolina Aguiar
    Taylor, Hugh S.
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2010, 54 (02) : 200 - 205
  • [29] Emerging therapies for the prevention or treatment of postmenopausal osteoporosis
    Sato, M
    Grese, TA
    Dodge, JA
    Bryant, HU
    Turner, CH
    JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (01) : 1 - 24
  • [30] Risedronate for prevention and treatment of osteoporosis in postmenopausal women
    Recker, RR
    Barger-Lux, J
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (03) : 465 - 477
12345